Swedencare AB (publ) (STO: SECARE)

Market Cap	7.50B
Revenue (ttm)	2.50B
Net Income (ttm)	62.10M
Shares Out	158.86M
EPS (ttm)	0.39
PE Ratio	120.97
Forward PE	35.37
Dividend	0.23 (0.49%)
Ex-Dividend Date	Apr 26, 2024

Volume	94,654
Average Volume	114,110
Open	48.00
Previous Close	47.04
Day's Range	47.20 - 48.74
52-Week Range	37.38 - 67.98
Beta	0.87
RSI	51.58
Earnings Date	Feb 13, 2025

About Swedencare AB

Swedencare AB (publ), together with its subsidiaries, develops, manufactures, markets, and sells animal healthcare products for cats, dogs, and horses in Sweden, the United Kingdom, Rest of Europe, North America, Asia, and internationally. The company offers animal nutritional supplements, treats, and grooming products under the Healthy Breeds name; pet supplements and topical products for various therapeutic areas, such as orthopedics, behavior, dermatology, odontostomatology, algology, gastroenterology, urology, nephrology, and ophthalmology ...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1993
• Employees: 560
• Stock Exchange: Nasdaq Stockholm
• Ticker Symbol: SECARE

Financial Performance

In 2023, Swedencare AB's revenue was 2.34 billion, an increase of 26.85% compared to the previous year's 1.84 billion. Earnings were 58.60 million, a decrease of -37.99%.